Prev Arrow Stocks

Chemours Company (The) ($CC) Stock Forecast: Up 7.4% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Chemours Company (The)?

Chemours (CC) is a chemical company with a wide range of products, including PFAS chemicals and specialty chemicals, serving industries such as chemical, pharmaceutical, and semiconductor sectors.

Why is Chemours Company (The) going up?

CC stock is up 7.4% on Jan 8, 2026 19:41

  • Despite legal challenges regarding PFAS chemicals in firefighter gear, Chemours (CC) saw notable bullish momentum in the stock market.
  • There is a possibility that the market is reacting strongly to the PFAS risks mentioned in a class-action lawsuit, potentially overshadowing the company's growth prospects and portfolio optimization in valuable applications.
  • Investors appear to be considering the legal implications alongside Chemours' strategic objectives and growth drivers, reflecting a mixed outlook on the company's future performance.
  • The expanding market for Perfluoroalkoxy Alkanes (PFA) and growth forecasts in key industries could be influencing the positive market trend, presenting potential opportunities for Chemours to enhance its product offerings and market presence.

CC Price Chart

CC Technical Analysis

CC News

Assessing Chemours (CC) Valuation After PFAS Class-Action Lawsuit Moves Forward in Montana

A Montana federal judge has allowed a class-action lawsuit over PFAS chemicals in firefighter gear to proceed against Chemours (CC), among other manufacturers. Despite recent stock gains, Chemours faces long-term declines and liability concerns. The company's valuation indicates it is 26.5% undervalued, suggesting the market might be overreacting to PFAS risks while overlooking potential future growth and portfolio optimization in high-value applications.

https://simplywall.st/stocks/us/materials/nyse-cc/chemours/news/assessing-chemours-cc-valuation-after-pfas-class-action-laws

0 News Article Image Assessing Chemours (CC) Valuation After PFAS Class-Action Lawsuit Moves Forward in Montana

Chemours (CC) Faces Expanded PFAS RICO Suit In Firefighter Gear Case Is Its Risk Story Shifting?

A recent Montana federal judge's refusal to dismiss a class-action lawsuit against Chemours, 3M, and others for concealing PFAS risks in firefighter gear has expanded Chemours' legal exposure to RICO and multi-state claims. This ruling complicates Chemours' investment narrative, emphasizing ongoing legal risks despite the company's efforts to highlight its product portfolio and financial guidance. Investors are now weighing the potential for significant legal liabilities against the company's operational goals and growth catalysts.

https://simplywall.st/stocks/us/materials/nyse-cc/chemours/news/chemours-cc-faces-expanded-pfas-rico-suit-in-firefighter-gea

1 News Article Image Chemours (CC) Faces Expanded PFAS RICO Suit In Firefighter Gear Case Is Its Risk Story Shifting?

Perfluoroalkoxy Alkanes Market to hit US$ 626.3 Million by 2030 | Major Companies 2026 - The Chemours Company, AGC Inc., Daikin Industries Ltd.

The global Perfluoroalkoxy Alkanes (PFA) Market, valued at US$ 430.4 million in 2022, is projected to reach US$ 626.3 million by 2030, exhibiting a CAGR of 4.8% during the forecast period from 2024 to 2031. This growth is driven by increasing demand for PFA in chemical, pharmaceutical, and semiconductor industries due to its chemical resistance, thermal stability, and non-stick properties. Key players like The Chemours Company, AGC Inc., and Daikin Industries Ltd., are expanding applications and capacities, particularly in Asia Pacific and North America.

https://www.openpr.com/news/4337692/perfluoroalkoxy-alkanes-market-to-hit-us-626-3-million-by-2030

2 News Article Image Perfluoroalkoxy Alkanes Market to hit US$ 626.3 Million by 2030 | Major Companies 2026 - The Chemours Company, AGC Inc., Daikin Industries Ltd.

Tell Chemours: Don’t mine near the Okefenokee

Environment America is urging Chemours CEO Denise Dignam to pledge against mining near Georgia's Okefenokee Swamp. The organization highlights that mining for titanium and other minerals could harm this unique ecosystem, which is home to diverse wildlife and enjoyed by many. They emphasize the potential risks to groundwater, habitat, and wildfire vulnerability.

https://environmentamerica.org/take-action/tell-chemours-dont-mine-near-the-okefenokee/

3 Missing News Article Image Tell Chemours: Don’t mine near the Okefenokee

Chemours Company (The) Price History

30.09.2025 - CC Stock was down 5.2%

  • The downward trend in CC's stock today is possibly linked to the expected decrease in Q3 earnings.
  • Investor response might have been adverse due to concerns about CC falling short of anticipated earnings, resulting in a sell-off of shares.
  • Uncertainty surrounding CC's upcoming earnings announcement might have impacted the bearish market performance observed today.

09.11.2025 - CC Stock was down 0.5%

  • The denial of Chemours' plea to secure confidential documents by a federal judge could lead to enhanced transparency but has also sparked concerns regarding potential negative impacts on investor sentiment from the information that may be divulged.
  • The appointment of Michael Foley as President of Titanium Technologies may indicate advancements in operations, yet investor apprehension persists due to persisting issues like PFAS litigation and regulatory uncertainties, resulting in a mixed response from the market.
  • The legal triumph of Carneys Point Township to pursue a billion-dollar cleanup lawsuit against chemical manufacturers, which includes Chemours, underscores the continuous legal hurdles faced by the company, further pressuring its stock performance.
  • The objection from Brunswick County commissioners to Chemours' expansion proposals stemming from worries about PFAS emissions and water contamination showcases mounting scrutiny and opposition from local authorities, introducing additional uncertainties to the company's future growth outlook.

14.10.2025 - CC Stock was down 5.4%

  • CC reported a Q3 profit rebound with $60M in net income, fueled by strong performance in Thermal & Specialized Solutions.
  • Despite the positive earnings, the market reacted bearishly, possibly due to operational disruptions.
  • Investors might be concerned about the mixed segment results, leading to the bearish movement in CC's stock price today.

15.11.2025 - CC Stock was down 5.0%

  • Michael Foley's appointment as the new president of Chemours' Titanium Technologies business signifies the company's commitment to enhancing profitability and operational efficiency.
  • The presence of hazardous "forever chemicals" such as GenX and TFA in the water supply, linked to Chemours' activities, has sparked concerns among experts and local authorities.
  • Reservations from local officials and environmental groups regarding Chemours' expansion intentions at its Fayetteville plant mirror a growing doubt about the company's capability to tackle PFAS contamination matters and prioritize public safety over production expansion.
  • The continued controversy surrounding Chemours' release of PFAS precursors and the possible health hazards related to TFA underscore the necessity for stricter regulations and transparency in the chemical sector to avert irreversible harm to the environment and communities.

11.11.2025 - CC Stock was up 5.3%

  • Investors responded positively to the news of Michael Foley's appointment as the new President of Titanium Technologies at Chemours, fueling a bullish trend in the company's stock. This appointment is seen as a potential driver for operational enhancements and strategic changes.
  • Despite ongoing public health and environmental controversies linked to PFAS chemicals, including opposition to Chemours' expansion plans, investors seem to have focused more on the optimism surrounding Foley's leadership, resulting in a positive market sentiment.
  • The market sentiment towards Chemours appears to be balanced, with the potential positive impact of Foley's new role offsetting concerns related to PFAS contamination and regulatory challenges. This balancing act reflects a level of optimism for the company's future trajectory under Foley's leadership.
  • The increased investor confidence in Chemours may have been influenced by the denial of the company's request to seal documents related to PFAS discharges, suggesting a commitment to transparency and compliance, which could enhance trust and bolster investor sentiment.

08.00.2026 - CC Stock was up 5.2%

  • The bullish movement in CC's stock is likely due to the positive industry outlook for Perfluoroalkoxy Alkanes (PFA), with projections anticipating substantial growth driven by demand across different sectors.
  • While legal challenges persist, investors appear more interested in the company's growth potential and operational progress.
  • Although the expansion of legal exposure initially raised concerns, market trends indicate optimism towards CC's ability to manage obstacles and leverage growth opportunities in the PFA market.
  • External advocacy against mining near the Okefenokee Swamp may impact CC's operations, but market sentiment seems to be primarily influenced by the company's overall market prospects and growth potential in the PFA industry.

06.00.2026 - CC Stock was up 5.3%

  • The bullish movement in CC stock today could be attributed to the projected growth in the PFA market, with an estimated value expected to reach US$ 626.3 million by 2030. This positive outlook indicates increasing demand for PFA due to its unique properties.
  • The environmental concerns raised by environmental groups urging Chemours CEO to pledge against mining near the Okefenokee Swamp might have also impacted the stock positively. By showing a commitment to environmental conservation, Chemours could be seen more favorably by investors and stakeholders.
  • The expansion of applications and capacities by key players like The Chemours Company in regions like Asia Pacific and North America could have further boosted investor confidence in the company's future prospects.

16.11.2025 - CC Stock was down 6.7%

  • The stock of Chemours Company (CC) experienced a strong bearish movement today, possibly influenced by:
  • Concerns over the company's declining Q3 revenue, particularly in segments like Freon Refrigerants and Foam, Propellants & Other sales.
  • Negative sentiment stemming from the discovery of dangerous chemicals like GenX in the US water supply, traced back to a Chemours factory, raising environmental and health-related alarms.
  • Opposition from local authorities and utility organizations towards Chemours' expansion plans, reflecting ongoing public health concerns and the company's historical accountability issues.
  • These factors combined may have contributed to investor uncertainty and a bearish trend in CC's stock price.

25.08.2025 - CC Stock was down 5.1%

  • An investigation initiated by the former Louisiana Attorney General into The Chemours Company's officers and directors has raised concerns among investors about potential legal liabilities and corporate governance issues.
  • The news of the investigation has likely contributed to the bearish movement in CC's stock as investors fear the uncertainties and potential legal consequences that may arise from the probe.
  • Market sentiment towards CC may remain negative in the near term until more clarity is provided regarding the investigation and its potential impact on the company's operations and financial performance.

17.08.2025 - CC Stock was up 5.3%

  • Energy Fuels achieving a milestone in manufacturing EV-grade rare earth magnets may suggest an increasing demand for tech components, potentially favoring CC's semiconductor business.
  • Progress in the U.S.-based supply chain for rare earth magnets could improve production efficiency and cost-effectiveness for companies like CC.
  • This development reflects a positive trend in the tech industry, likely enhancing investor confidence in CC's future outlook and contributing to the uptrend in its stock price.

08.00.2026 - CC Stock was up 7.4%

  • Despite legal challenges regarding PFAS chemicals in firefighter gear, Chemours (CC) saw notable bullish momentum in the stock market.
  • There is a possibility that the market is reacting strongly to the PFAS risks mentioned in a class-action lawsuit, potentially overshadowing the company's growth prospects and portfolio optimization in valuable applications.
  • Investors appear to be considering the legal implications alongside Chemours' strategic objectives and growth drivers, reflecting a mixed outlook on the company's future performance.
  • The expanding market for Perfluoroalkoxy Alkanes (PFA) and growth forecasts in key industries could be influencing the positive market trend, presenting potential opportunities for Chemours to enhance its product offerings and market presence.

07.10.2025 - CC Stock was down 11.2%

  • Chemours (CC) had a bearish movement today following a Q3 earnings report that missed estimates by -16.67%.
  • The observation of oversold materials stocks may not have been enough to counter the negative impact of the earnings miss on Chemours.
  • Investors reacted negatively to the company's financial performance, leading to a sell-off of the stock.
  • The market sentiment towards Chemours seems to have shifted due to the disappointing earnings results, overshadowing any potential buying opportunities in the materials sector.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.